Annual EBITDA
-$34.66 M
NaN%
December 31, 2023
Summary
- As of February 7, 2025, RAPP annual EBITDA is -$34.66 million
- RAPP annual EBITDA is now at all-time high.
Performance
RAPP EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$21.42 M
-$829.00 K-4.03%
September 30, 2024
Summary
- As of February 7, 2025, RAPP quarterly EBITDA is -$21.42 million, with the most recent change of -$829.00 thousand (-4.03%) on September 30, 2024.
- Over the past year, RAPP quarterly EBITDA has dropped by -$4.48 million (-26.44%).
- RAPP quarterly EBITDA is now -313.85% below its all-time high of -$5.18 million, reached on March 31, 2023.
Performance
RAPP Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$72.29 M
-$11.88 M-19.66%
September 30, 2024
Summary
- As of February 7, 2025, RAPP TTM EBITDA is -$72.29 million, with the most recent change of -$11.88 million (-19.66%) on September 30, 2024.
- Over the past year, RAPP TTM EBITDA has dropped by -$25.86 million (-55.70%).
- RAPP TTM EBITDA is now -1296.70% below its all-time high of -$5.18 million, reached on March 31, 2023.
Performance
RAPP TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
RAPP EBITDA Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | - | -26.4% | -55.7% |
3 y3 years | - | -313.9% | -1296.7% |
5 y5 years | - | -313.9% | -1296.7% |
RAPP EBITDA Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | at low | -313.9% | at low | -1296.7% | at low |
5 y | 5-year | at high | at low | -313.9% | at low | -1296.7% | at low |
alltime | all time | at high | at low | -313.9% | at low | -1296.7% | at low |
Rapport Therapeutics EBITDA History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$21.42 M(+4.0%) | -$72.29 M(+19.7%) |
Jun 2024 | - | -$20.59 M(+21.5%) | -$60.41 M(+30.1%) |
Mar 2024 | - | -$16.94 M(+27.0%) | -$46.43 M(+33.9%) |
Dec 2023 | -$34.66 M | - | - |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2023 | - | -$13.34 M(+39.8%) | -$34.66 M(+62.5%) |
Sep 2023 | - | -$9.54 M(+44.4%) | -$21.33 M(+81.0%) |
Jun 2023 | - | -$6.61 M(+27.7%) | -$11.79 M(+127.7%) |
Mar 2023 | - | -$5.18 M | -$5.18 M |
FAQ
- What is Rapport Therapeutics annual EBITDA?
- What is the all time high annual EBITDA for Rapport Therapeutics?
- What is Rapport Therapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for Rapport Therapeutics?
- What is Rapport Therapeutics quarterly EBITDA year-on-year change?
- What is Rapport Therapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for Rapport Therapeutics?
- What is Rapport Therapeutics TTM EBITDA year-on-year change?
What is Rapport Therapeutics annual EBITDA?
The current annual EBITDA of RAPP is -$34.66 M
What is the all time high annual EBITDA for Rapport Therapeutics?
Rapport Therapeutics all-time high annual EBITDA is -$34.66 M
What is Rapport Therapeutics quarterly EBITDA?
The current quarterly EBITDA of RAPP is -$21.42 M
What is the all time high quarterly EBITDA for Rapport Therapeutics?
Rapport Therapeutics all-time high quarterly EBITDA is -$5.18 M
What is Rapport Therapeutics quarterly EBITDA year-on-year change?
Over the past year, RAPP quarterly EBITDA has changed by -$4.48 M (-26.44%)
What is Rapport Therapeutics TTM EBITDA?
The current TTM EBITDA of RAPP is -$72.29 M
What is the all time high TTM EBITDA for Rapport Therapeutics?
Rapport Therapeutics all-time high TTM EBITDA is -$5.18 M
What is Rapport Therapeutics TTM EBITDA year-on-year change?
Over the past year, RAPP TTM EBITDA has changed by -$25.86 M (-55.70%)